Cargando…

Notalgia paresthetica: clinical features, radiological evaluation, and a novel therapeutic option

BACKGROUND/OBJECTIVE: Notalgia paresthetica (NP) is a sensory neuropathy characterized by localized pruritus and pain, presenting with or without a well-circumscribed hyperpigmented patch in the upper back. Abnormal sensations, such as burning, numbness, and paresthesia are often present in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Mülkoğlu, Cevriye, Nacır, Barış
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229619/
https://www.ncbi.nlm.nih.gov/pubmed/32416719
http://dx.doi.org/10.1186/s12883-020-01773-6
_version_ 1783534800058974208
author Mülkoğlu, Cevriye
Nacır, Barış
author_facet Mülkoğlu, Cevriye
Nacır, Barış
author_sort Mülkoğlu, Cevriye
collection PubMed
description BACKGROUND/OBJECTIVE: Notalgia paresthetica (NP) is a sensory neuropathy characterized by localized pruritus and pain, presenting with or without a well-circumscribed hyperpigmented patch in the upper back. Abnormal sensations, such as burning, numbness, and paresthesia are often present in patients with NP. In this study, we clinically and radiologically analyzed patients with NP. The literature contains studies describing lidocaine treatments involving intravenous and topical applications for NP. We also investigated the effect of intradermal lidocaine injection on patients with NP. METHODS: A total of 80 patients (45 patients with NP and 35 suffering from dorsalgia without NP) were included in the study. The age, gender and body mass index (BMI) of the patients, and the characteristics of their symptoms were recorded. The severity of pain and pruritus was assessed by the Visual Analog Scale (VAS). Radiography and magnetic resonance imaging of the spine were performed. In this study, we intradermally administered lidocaine diluted with saline into the upper back over three sessions. 1 cc 2% lidocaine was diluted with 5 cc 0.9% saline, and a total of 6 cc lidocaine mixture was obtained. The injection was performed locally at 1-cm intervals around the hyperpigmented patch and segmentally along the C2-T6 spinous processes. These patients were called for a follow-up at the second and fourth weeks and third month. RESULTS: There was no statistically significant difference between the two groups in terms of age, BMI, VAS-pain score, and duration of symptoms (p > 0.05 for all). Forty-six cervical and/or thoracic degenerative changes or herniated nucleus pulposus (HNP) were detected in patients with NP. There was a significantly higher number of HNP at the C6–7 segment and cervical degenerative changes in the NP group (p < 0.05). The VAS-pain and VAS-pruritus scores were significantly decreased at all follow-up sessions, and improvement was sustained by lidocaine up to the third month. CONCLUSION: Cervical degenerative changes and HNP of the C6–7 segment seem to be contributing factors for NP. Local lidocaine can be effective for pain relief and pruritus in NP.
format Online
Article
Text
id pubmed-7229619
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72296192020-05-27 Notalgia paresthetica: clinical features, radiological evaluation, and a novel therapeutic option Mülkoğlu, Cevriye Nacır, Barış BMC Neurol Research Article BACKGROUND/OBJECTIVE: Notalgia paresthetica (NP) is a sensory neuropathy characterized by localized pruritus and pain, presenting with or without a well-circumscribed hyperpigmented patch in the upper back. Abnormal sensations, such as burning, numbness, and paresthesia are often present in patients with NP. In this study, we clinically and radiologically analyzed patients with NP. The literature contains studies describing lidocaine treatments involving intravenous and topical applications for NP. We also investigated the effect of intradermal lidocaine injection on patients with NP. METHODS: A total of 80 patients (45 patients with NP and 35 suffering from dorsalgia without NP) were included in the study. The age, gender and body mass index (BMI) of the patients, and the characteristics of their symptoms were recorded. The severity of pain and pruritus was assessed by the Visual Analog Scale (VAS). Radiography and magnetic resonance imaging of the spine were performed. In this study, we intradermally administered lidocaine diluted with saline into the upper back over three sessions. 1 cc 2% lidocaine was diluted with 5 cc 0.9% saline, and a total of 6 cc lidocaine mixture was obtained. The injection was performed locally at 1-cm intervals around the hyperpigmented patch and segmentally along the C2-T6 spinous processes. These patients were called for a follow-up at the second and fourth weeks and third month. RESULTS: There was no statistically significant difference between the two groups in terms of age, BMI, VAS-pain score, and duration of symptoms (p > 0.05 for all). Forty-six cervical and/or thoracic degenerative changes or herniated nucleus pulposus (HNP) were detected in patients with NP. There was a significantly higher number of HNP at the C6–7 segment and cervical degenerative changes in the NP group (p < 0.05). The VAS-pain and VAS-pruritus scores were significantly decreased at all follow-up sessions, and improvement was sustained by lidocaine up to the third month. CONCLUSION: Cervical degenerative changes and HNP of the C6–7 segment seem to be contributing factors for NP. Local lidocaine can be effective for pain relief and pruritus in NP. BioMed Central 2020-05-16 /pmc/articles/PMC7229619/ /pubmed/32416719 http://dx.doi.org/10.1186/s12883-020-01773-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Mülkoğlu, Cevriye
Nacır, Barış
Notalgia paresthetica: clinical features, radiological evaluation, and a novel therapeutic option
title Notalgia paresthetica: clinical features, radiological evaluation, and a novel therapeutic option
title_full Notalgia paresthetica: clinical features, radiological evaluation, and a novel therapeutic option
title_fullStr Notalgia paresthetica: clinical features, radiological evaluation, and a novel therapeutic option
title_full_unstemmed Notalgia paresthetica: clinical features, radiological evaluation, and a novel therapeutic option
title_short Notalgia paresthetica: clinical features, radiological evaluation, and a novel therapeutic option
title_sort notalgia paresthetica: clinical features, radiological evaluation, and a novel therapeutic option
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229619/
https://www.ncbi.nlm.nih.gov/pubmed/32416719
http://dx.doi.org/10.1186/s12883-020-01773-6
work_keys_str_mv AT mulkoglucevriye notalgiaparestheticaclinicalfeaturesradiologicalevaluationandanoveltherapeuticoption
AT nacırbarıs notalgiaparestheticaclinicalfeaturesradiologicalevaluationandanoveltherapeuticoption